Denali Advisors’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ORGO
SCM
Denali Advisors's ORGO Position: Q2 2024 in Review
Denali Advisors sold out of Organogenesis Holdings (ORGO) in Q2 2024, closing a stake of 45,500 shares — an estimated $129K sold.
Denali Advisors first reported a position in ORGO in Q1 2024 and held it in 1 quarter. The position peaked at $129K in Q1 2024. 115 funds tracked by Wall St. Rank hold ORGO as of Q2 2024.
- Denali Advisors reported no remaining Organogenesis Holdings position as of Q2 2024 after selling out during the quarter.
- Denali Advisors sold 45,500 Organogenesis Holdings shares in Q2 2024, an estimated $129K.
- Denali Advisors first reported a position in Organogenesis Holdings in Q1 2024 and held it in 1 quarter.
- Denali Advisors's Organogenesis Holdings position peaked at $129K in Q1 2024.
- 115 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2024.
Based on Denali Advisors's 13F filing for Q2 2024, filed 9 Aug 2024.